Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
Introduction The optimal duration of dual anti-platelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still a matter of debate. Biomarkers may help to identify patients who will benefit from extended DAPT. The aim of the study was to test the interaction between lipid paramete...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Termedia Publishing House
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/456b7b6919d84e3b8d6ac64cf3909fbe |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!